Robert Andrew Berman is Chief Executive Officer of enVVeno Medical Corp. Currently has a direct ownership of 210,236 shares of NVNO, which is worth approximately $716,904. The most recent transaction as insider was on Jun 27, 2022, when has been sold 2,500 shares (Common Stock) at a price of $3.8 per share, resulting in proceeds of $9,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $716,904

ROBERT ANDREW BERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 27 2022
BUY
Open market or private purchase
$9,500 $3.8 p/Share
2,500 Added 1.18%
210,236 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
-
200,000 Added 49.05%
207,736 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$14,860 $7.43 p/Share
2,000 Added 20.54%
7,736 Common Stock
Nov 16 2021
BUY
Open market or private purchase
$15,740 $7.87 p/Share
2,000 Added 25.85%
5,736 Common Stock
May 18 2021
BUY
Open market or private purchase
$16,410 $5.47 p/Share
3,000 Added 44.54%
3,736 Common Stock, $0.00001...
RAB

Robert Andrew Berman

Chief Executive Officer
Irvine, CA

Track Institutional and Insider Activities on NVNO

Follow enVVeno Medical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVNO shares.

Notify only if

Insider Trading

Get notified when an En V Veno Medical Corp insider buys or sells NVNO shares.

Notify only if

News

Receive news related to enVVeno Medical Corp

Track Activities on NVNO